4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.